BURLINGTON, Mass., Jan. 5, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 11, 2023, which includes a presentation beginning at 3:45 pm PST. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Azenta is headquartered in Massachusetts, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations
978.262.2635
This email address is being protected from spambots. You need JavaScript enabled to view it.

Sherry Dinsmore
978.262.2400
This email address is being protected from spambots. You need JavaScript enabled to view it.